Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large‐volume center

Sung‐Gyu Lee, Shin Hwang, Deok‐Bog Moon, Chul‐Soo Ahn, Ki‐Hun Kim, Kyu‐Bo Sung, Gi‐Young Ko, Kwang‐Min Park, Tae‐Yong Ha, Gi‐Won Song – 25 June 2008 – The currently available indication criteria of living donor liver transplantation (LDLT) for patients with hepatocellular carcinoma (HCC) have high prognostic power but insufficient discriminatory power. On the basis of single‐center results from 221 HCC patients undergoing LDLT, we modified the indication criteria for LDLT to expand recipient selection without increasing the posttransplant recurrence of HCC.

Adenosine‐dependent activation of hypoxia‐inducible factor‐1 induces late preconditioning in liver cells

Elisa Alchera, Lorenza Tacchini, Chiara Imarisio, Caterina Dal Ponte, Cristina De Ponti, Elena Gammella, Gaetano Cairo, Emanuele Albano, Rita Carini – 20 June 2008 – The cellular mechanisms by which ischemic preconditioning increases liver tolerance to ischemia/reperfusion injury are still poorly understood. This study investigated the role of the hypoxia‐inducible factor‐1 (HIF‐1) in the protection associated with the late phase of liver preconditioning.

Autocrine insulin‐like growth factor‐II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis

Tanja Nussbaum, Jana Samarin, Volker Ehemann, Michaela Bissinger, Eduard Ryschich, Akmal Khamidjanov, Xiaolei Yu, Norbert Gretz, Peter Schirmacher, Kai Breuhahn – 20 June 2008 – The protumorigenic insulin‐like growth factor (IGF)‐II is highly expressed in a significant fraction of human hepatocellular carcinomas (HCC). However, a functional dissection that clarifies the contribution of IGF‐II–binding receptors in tumor progression and a respective molecular characterization of IGF‐II signaling has not been performed.

Hepatitis C virus replication is inhibited by 22β‐methoxyolean‐12‐ene‐3β, 24(4β)‐diol (ME3738) through enhancing interferon‐β

Yoichi Hiasa, Hiroyuki Kuzuhara, Yoshio Tokumoto, Ichiro Konishi, Nobuyuki Yamashita, Bunzo Matsuura, Kojiro Michitaka, Raymond T. Chung, Morikazu Onji – 20 June 2008 – A derivative of soyasapogenol, 22β‐methoxyolean‐12‐ene‐3β, 24(4β)‐diol (ME3738), ameliorates liver injury induced by Concanavalin A in mice.

An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor‐α

Benjamin D. Cosgrove, Connie Cheng, Justin R. Pritchard, Donna B. Stolz, Douglas A. Lauffenburger, Linda G. Griffith – 20 June 2008 – Tumor necrosis factor‐α (TNF) is an inflammatory cytokine that induces context‐dependent proliferation, survival, and apoptosis responses in hepatocytes. TNF stimulates and enhances growth factor‐mediated hepatocyte proliferation and survival following partial hepatectomy, but also acts in concert with other inflammatory cytokines of the innate immune response during viral infection to induce apoptosis in hepatocytes.

Comorbidity and survival of Danish cirrhosis patients: A nationwide population‐based cohort study

Peter Jepsen, Hendrik Vilstrup, Per Kragh Andersen, Timothy L. Lash, Henrik Toft Sørensen – 20 June 2008 – Patients with liver cirrhosis have a high mortality, not just from cirrhosis‐related causes, but also from other causes. This observation indicates that many patients with cirrhosis have other chronic diseases, yet the prognostic impact of comorbidities has not been examined.

Subscribe to